FDA Adverse Event Injury Summary report: N

SOLOGRIP III HANDPIECE

MDR report key: 3770030 · Received April 24, 2014

Report

Report Number
2950727-2014-00009
Event Type
Injury
Date Received
April 24, 2014
Date of Event
March 10, 2014
Report Date
April 21, 2014
Manufacturer
CARDIOGENESIS CORPORATION
Product Code
MNO
PMA / PMN Number
P970029
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THIS EVENT WAS REPORTED THROUGH THE (B)(4) REGISTRY. THE (B)(6) PATIENT UNDERWENT THE TMR+CABG PROCEDURE ON (B)(6) 2014 WITH A TOTAL OF 18 CHANNELS PLACED. THE PATIENT EXPERIENCED VENTRICULAR ARRHYTHMIA THE SAME DAY. THE NON SUSTAINED VENTRICULAR TACHYCARDIA WAS SUCCESSFULLY TREATED WITH AMIODARONE. A REVIEW OF MANUFACTURING AND INSPECTION RECORDS FROM EACH POSSIBLE LOT WAS PERFORMED AND ALL COMPONENTS WERE FOUND TO MEET SPECIFICATION. VENTRICULAR ARRHYTHMIA A COMMON EARLY ADVERSE EVENT AFTER CORONARY ARTERY BYPASS GRAFT PROCEDURES WITH OR WITHOUT ADJUNCTIVE TMR. ADEQUATE PRECAUTIONS AND WARNINGS ARE PRESENT IN THE PRODUCT'S INSTRUCTIONS FOR USE.

Additional Manufacturer Narrative · 1

THIS INVESTIGATION IS CURRENTLY ONGOING. ANY ADDITIONAL INFORMATION WILL BE PROVIDED IN THE FOLLOW-UP REPORT.

Description of Event or Problem · 1

ACCORDING TO THE REPORT, THE (B)(6) PATIENT UNDERWENT THE TMR+CABG PROCEDURE ON (B)(6) 2014 WITH A TOTAL OF 18 CHANNELS PLACED. THE PATIENT EXPERIENCED VENTRICULAR ARRHYTHMIA THE SAME DAY. THE NON SUSTAINED VENTRICULAR TACHYCARDIA WAS SUCCESSFULLY TREATED WITH AMIODARONE.

Description of Event or Problem · 1

ACCORDING TO THE REPORT, THE (B)(6) PATIENT UNDERWENT THE TMR+CABG PROCEDURE ON (B)(6) 2014 WITH A TOTAL OF 18 CHANNELS PLACED. THE PATIENT EXPERIENCED VENTRICULAR ARRHYTHMIA THE SAME DAY. THE NON SUSTAINED VENTRICULAR TACHYCARDIA WAS SUCCESSFULLY TREATED WITH AMIODARONE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
249853 SOLOGRIP III HANDPIECE TRANSMYOCARDIAL REVASCULARIZATION LASER HANDPIECE MNO CARDIOGENESIS CORPORATION HP-SG3 TA-04026

Patients

Seq Age Sex Outcome Treatment
1 57 YR Other